NDC 0591-0492-01 - Mexiletine HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0492
- Requested NDC
- 0591-0492-01
- Package NDCs from labels
- 0591-0492-01, 0591-0492-05
- Manufacturer
- Watson Laboratories, Inc.
- Effective date
- 2008-04-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mexiletine Hydrochloride Capsules USP Rx only | Watson Laboratories, Inc. | 2008-04-29 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0492-01 | Mexiletine HCl | 100 in 1 BOTTLE | CAPSULE | 100 | 2 | |
| 0591-0492-05 | Mexiletine HCl | 500 in 1 BOTTLE | CAPSULE | 500 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Bryant Ranch Prepack | 9099b620-eae9-48f9-9d5f-8fd22c32b2b0 | 2024-04-04 | Warnings, Adverse reactions | 1362706 |
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Bryant Ranch Prepack | 41930321-15e3-4ddf-ba5d-3655ce5f2923 | 2023-10-24 | Warnings, Adverse reactions | 1362712 |
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Bryant Ranch Prepack | 217fbd7a-1052-42e4-9e84-70519b7b0b7a | 2023-10-24 | Warnings, Adverse reactions | 1362720 |
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 6dbf86f7-2b2d-40fb-868b-ee7d7a95556e | 2023-07-28 | Boxed warning, Warnings, Adverse reactions | 1362706 1362712 1362720 |
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Senores Pharmaceuticals, Inc. | c4a60f9e-fed1-4172-adc4-0be84ac65db9 | 2023-06-16 | Boxed warning, Warnings, Adverse reactions | 1362706 1362712 1362720 |
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 2d0c61ca-4c99-42f9-8f00-e0e9d2672a39 | 2023-04-27 | Warnings, Adverse reactions | 1362706 1362712 1362720 |
| Mexiletine hydrochloride | MEXILETINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 8b20e850-037b-4c16-a57d-c3d4909f147a | 2022-11-16 | Warnings, Adverse reactions | 1362706 1362712 1362720 |
| Mexiletine Hydrochloride | MEXILETINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 693da40b-26d4-40d6-87d1-158e256f40ab | 2022-10-30 | Boxed warning, Warnings, Adverse reactions | 1362706 1362712 1362720 |
| 613F0349-1D4C-9F2D-3A6C-FD6024230418 | AB73778B-6794-441C-B127-610A6D0733EA | 2008-04-29 | Adverse reactions | 613F0349-1D4C-9F2D-3A6C-FD6024230418 AB73778B-6794-441C-B127-610A6D0733EA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.